- Contract research organizations
- Asia
- Indonesia
- Equilab International
Equilab International in Indonesia

E-mail: info@equilab-int.com; ronal.simanjuntak@equilab-int.com; mesulam.esther@equilab-int.com
Web: https://www.equilab-int.com/
Phone: +62 21 7695513
Address:
-
Jl. RS. Fatmawati Persil 33, Jakarta Selatan 12430, Indonesia
About Equilab International
Equilab is established since 2003 and as the first Contract Research Organization (CRO) in Indonesia. They are also the first CRO in Southeast Asia that recognized by the World Health Organization (WHO). Their main services are structured into four main areas: Bioequivalence and Pharmacokinetic Studies, Clinical Trials, Laboratory Testing, and Dermatology Testing. Moreover, their clinical study reports have been approved in Europe (including the UK, Germany, the Netherlands, Poland, Spain, and Hungary), all ASEAN countries, and several countries in Asia and Africa.
They actively engage with the regulatory authorities, both the local and also overseas. With their strong experiences in managing clinical trials in Indonesia, Equilab International has proved that Material Transfer Agreement (MTA) approval is no longer a barrier to conduct clinical trials in Indonesia. They also show strong experiences in conducting clinical trials for vaccines, oncology, hormonal, nutrition, cardiovascular, endocrine, and dermatology.
Having an accredited facility, Equilab International can also be your choice of central laboratory to support your clinical trials in Indonesia. It has both of clinical and analytical laboratories under a controlled automated system. The complete set of skillful operation team and acknowledged facility has made Equilab International become the leading Clinical Research Organization in Indonesia and Southeast Asia.